APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested. It contains a phenylalanine amino acid residue in its structure.
Legality Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.
See also
5F-AB-PINACA 5F-ADB 5F-AMB 5F-APINACA AB-FUBINACA AB-CHFUPYCA AB-CHMINACA AB-PINACA ADB-CHMINACA ADB-FUBINACA ADB-PINACA ADBICA APICA APINACA APP-BINACA BMS-F MDMB-CHMICA MDMB-FUBINACA PX-1 PX-2 PX-3
References